Cargando…

Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression

INTRODUCTION: Chronic spinal compression is a common complication of spinal cord injury (SCI), which can lead to spinal stenosis or herniated discs. The ensuing neuropathic pain is often associated with the activation of microglia. In this investigation, our objective was to explore whether modifyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Quan, Yang, Zongde, Wang, Kun, Chen, Zhi, Shen, Hongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366611/
https://www.ncbi.nlm.nih.gov/pubmed/37497210
http://dx.doi.org/10.3389/fimmu.2023.1191188
_version_ 1785077205182709760
author Li, Quan
Yang, Zongde
Wang, Kun
Chen, Zhi
Shen, Hongxing
author_facet Li, Quan
Yang, Zongde
Wang, Kun
Chen, Zhi
Shen, Hongxing
author_sort Li, Quan
collection PubMed
description INTRODUCTION: Chronic spinal compression is a common complication of spinal cord injury (SCI), which can lead to spinal stenosis or herniated discs. The ensuing neuropathic pain is often associated with the activation of microglia. In this investigation, our objective was to explore whether modifying the levels of chemokine (C-C motif) ligand 2 (Ccl2) in microglia could alleviate neuropathic pain resulting from chronic spinal compression. METHODS: We used a public database to look for major altered gene associated in a SCI model established in rats. We then employed adeno-associated virus (AAV) vectors, expressing siRNA for the identified significantly altered gene under a microglia-specific TMEM119 promoter. We also tested the impact of this treatment in microglia in vivo on the severity of chronic spinal compression and associated pain using a ttw mouse model for progressive spinal compression. RESULTS: We identified chemokine (C-C motif) ligand 2 (Ccl2) as the primary gene altered in microglia within a rat SCI model, utilizing a public database. Microglial Ccl2 levels were then found to be significantly elevated in disc specimens from SCI patients diagnosed with chronic spinal compression and strongly correlated with the Thompson classification of the degeneration level and pain score. Depletion of Ccl2 in microglia-specific TMEM119 promoter were developed to transfect mouse microglia in vitro, resulting in a proinflammatory to anti-inflammatory phenotypic adaption. In vivo depletion of Ccl2 in microglia mitigated the severity of chronic spinal compression and related pain in ttw mice, likely due to significant changes in pain-associated cytokines and factors. CONCLUSION: Disc microglia expressing high levels of Ccl2 may contribute to chronic spinal compression and SCI-associated pain. Therapeutically targeting Ccl2 in microglia could offer a potential avenue for treating chronic spinal compression and SCI-associated pain.
format Online
Article
Text
id pubmed-10366611
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103666112023-07-26 Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression Li, Quan Yang, Zongde Wang, Kun Chen, Zhi Shen, Hongxing Front Immunol Immunology INTRODUCTION: Chronic spinal compression is a common complication of spinal cord injury (SCI), which can lead to spinal stenosis or herniated discs. The ensuing neuropathic pain is often associated with the activation of microglia. In this investigation, our objective was to explore whether modifying the levels of chemokine (C-C motif) ligand 2 (Ccl2) in microglia could alleviate neuropathic pain resulting from chronic spinal compression. METHODS: We used a public database to look for major altered gene associated in a SCI model established in rats. We then employed adeno-associated virus (AAV) vectors, expressing siRNA for the identified significantly altered gene under a microglia-specific TMEM119 promoter. We also tested the impact of this treatment in microglia in vivo on the severity of chronic spinal compression and associated pain using a ttw mouse model for progressive spinal compression. RESULTS: We identified chemokine (C-C motif) ligand 2 (Ccl2) as the primary gene altered in microglia within a rat SCI model, utilizing a public database. Microglial Ccl2 levels were then found to be significantly elevated in disc specimens from SCI patients diagnosed with chronic spinal compression and strongly correlated with the Thompson classification of the degeneration level and pain score. Depletion of Ccl2 in microglia-specific TMEM119 promoter were developed to transfect mouse microglia in vitro, resulting in a proinflammatory to anti-inflammatory phenotypic adaption. In vivo depletion of Ccl2 in microglia mitigated the severity of chronic spinal compression and related pain in ttw mice, likely due to significant changes in pain-associated cytokines and factors. CONCLUSION: Disc microglia expressing high levels of Ccl2 may contribute to chronic spinal compression and SCI-associated pain. Therapeutically targeting Ccl2 in microglia could offer a potential avenue for treating chronic spinal compression and SCI-associated pain. Frontiers Media S.A. 2023-07-11 /pmc/articles/PMC10366611/ /pubmed/37497210 http://dx.doi.org/10.3389/fimmu.2023.1191188 Text en Copyright © 2023 Li, Yang, Wang, Chen and Shen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Quan
Yang, Zongde
Wang, Kun
Chen, Zhi
Shen, Hongxing
Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title_full Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title_fullStr Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title_full_unstemmed Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title_short Suppression of microglial Ccl2 reduces neuropathic pain associated with chronic spinal compression
title_sort suppression of microglial ccl2 reduces neuropathic pain associated with chronic spinal compression
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366611/
https://www.ncbi.nlm.nih.gov/pubmed/37497210
http://dx.doi.org/10.3389/fimmu.2023.1191188
work_keys_str_mv AT liquan suppressionofmicroglialccl2reducesneuropathicpainassociatedwithchronicspinalcompression
AT yangzongde suppressionofmicroglialccl2reducesneuropathicpainassociatedwithchronicspinalcompression
AT wangkun suppressionofmicroglialccl2reducesneuropathicpainassociatedwithchronicspinalcompression
AT chenzhi suppressionofmicroglialccl2reducesneuropathicpainassociatedwithchronicspinalcompression
AT shenhongxing suppressionofmicroglialccl2reducesneuropathicpainassociatedwithchronicspinalcompression